Education
About Us
Working with TipRanks
Follow Us
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
RESEARCH TOOLSreports
Brainstorm Cell Therapeutics (BCLI) Ownership Overview
9.99% Insiders
0.98% Mutual Funds
13.21% Other Institutional Investors
0.34% ETFs
75.49% Public Companies and Individual Investors
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. Approximately 14.52% of the company’s stock is owned by Institutional Investors, 9.99% is owned by Insiders, and 75.49% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 02, 2024 | xxxxxxxxxxxxx | $11119 | |
Jul 24, 2024 | xxxxxxxxxxxxx | $22050 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 334,349 | Insider | 4.21% | 367,784 | |
| 79,515 | Insider | 1.00% | 87,467 | |
| 68,464 | Insider | 0.86% | 75,310 | |
| 52,000 | Insider | 0.66% | 57,200 | |
| 48,229 | Insider | 0.61% | 53,052 | |
| 47,541 | Institution | 0.60% | 52,295 | |
| 44,349 | Insider | 0.56% | 48,784 | |
| 43,777 | Insider | 0.55% | 48,155 | |
| 41,054 | Insider | 0.52% | 45,159 | |
| 31,465 | Insider | 0.40% | 34,612 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 47,541 | Institution | 0.60% | 52,295 | |
| 26,734 | Institution | 0.34% | 29,407 | |
| 3,152 | Institution | 0.04% | 3,467 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 26,734 | Institution | 0.34% | 34,754 |
FAQ
Who Owns Brainstorm Cell Therapeutics (BCLI)?
According to the latest TipRanks data, approximately 13.21% of the company's stock is held by institutional investors, 9.99% is held by insiders, and 75.49% is held by retail investors.
What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.21% of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors.
What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.49% of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors.
Who owns the most shares of Brainstorm Cell Therapeutics (BCLI)?
Chaim Lebovits owns the most shares of Brainstorm Cell Therapeutics (BCLI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.